Alexander B. Taylor
Immunology and Microbiology · University of Michigan
Publications
204
Citations
6,153
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
Typically publishes in teams of ~7 · 19% small-team papers (≤3 authors) · across 26 venues
- Resolution of R-loops and transcription–replication conflicts by SETX–BRCA1–BARD1 complex
Nature Structural & Molecular Biology · 2026
- Author Correction: Structural insights into BCDX2 complex function in homologous recombination
Nature · 2026
- Crystal Structure of Měnglà Virus Nucleoprotein Bound by a Poorly Cross-Reactive Anti-Marburg Virus Nanobody Highlights a Single Amino Acid Affinity Switch, a Feature Also Evident in Dehong Virus
ACS Infectious Diseases · 2026
- Crystal Structureof Mengla Virus NucleoproteinBound by a Poorly Cross-Reactive Anti-Marburg Virus Nanobody Highlightsa Single Amino Acid Affinity Switch, a Feature Also Evident in DehongVirus
Figshare · 2026
- Figure SI6 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Table S1B from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Table S1A from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Data from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Figure SI5 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Figure SI1 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Figure SI3 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Figure SI2 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Figure SI4 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026
- Structural basis for the mechanism and stability of the EEPD1 5′ endonuclease
Journal of Biological Chemistry · 2026
- Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling
Nature Communications · 2025
- Journal of Biological Chemistry×6
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Biochemistry×4
- The FASEB Journal×4
- Nature Communications×3
- Tao Huang
Immunology and Microbiology · Purdue University West Lafayette
- Timothy Visclosky
Immunology and Microbiology · University of Michigan
- Thiago A. Pereira
Immunology and Microbiology · Indiana University
- James E. Penner‐Hahn
Chemistry · University of Michigan
- Jiayi Tian
Chemistry · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile